Phathom Pharmaceuticals Inc (PHAT)
4.85 x 1 5.09 x 2
Post-market by (Cboe BZX)
4.84 +0.43 (+9.75%) 03/17/25 [NASDAQ]
4.85 x 1 5.09 x 2
Post-market 5.09 +0.25 (+5.17%) 19:45 ET
for Mon, Mar 17th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 29,664 | 16,352 | 7,324 | 1,912 | 0 |
| Cost of Goods | 3,815 | 2,356 | 1,376 | 426 | N/A |
| Gross Profit | 25,849 | 13,996 | 5,948 | 1,486 | N/A |
| Operating Expenses | 86,081 | 85,148 | 83,624 | 71,866 | 70,557 |
| Operating Income | -59,417 | -70,796 | -77,300 | -69,954 | -69,875 |
| Interest Expense | 18,593 | 18,484 | 17,764 | 17,168 | 13,029 |
| Other Income | 3,559 | 3,703 | 3,618 | 4,270 | 3,334 |
| Pre-tax Income | -74,451 | -85,577 | -91,446 | -82,852 | -79,570 |
| Net Income Continuous | -74,451 | -85,577 | -91,446 | -82,852 | -79,570 |
| Net Income | $-74,451 | $-85,577 | $-91,446 | $-82,852 | $-79,570 |
| EPS Basic Total Ops | -0.99 | -1.32 | -1.56 | -1.42 | -1.44 |
| EPS Basic Continuous Ops | -0.99 | -1.32 | -1.56 | -1.42 | -1.43 |
| EPS Diluted Total Ops | -0.99 | -1.32 | -1.56 | -1.42 | -1.44 |
| EPS Diluted Continuous Ops | -0.99 | -1.32 | -1.56 | -1.42 | -1.43 |
| EPS Diluted Before Non-Recurring Items | -0.88 | -1.32 | -1.35 | -1.42 | -0.80 |
| EBITDA(a) | $-58,595 | $-70,016 | $-76,603 | $-69,266 | $-69,806 |